Anavex Life Sciences (AVXL) EPS (Basic) Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.94% |
| Sep 30, 2025 | -1.92% |
| Jun 30, 2025 | -7.78% |
| Mar 31, 2025 | -1.61% |
| Dec 31, 2024 | -3.13% |
| Sep 30, 2024 | -4.94% |
| Jun 30, 2024 | -1.49% |
| Mar 31, 2024 | 2.82% |
| Dec 31, 2023 | 6.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -18.47% |
| Mar 31, 2023 | -9.10% |
| Dec 31, 2022 | -13.07% |
| Sep 30, 2022 | -187.23% |
| Jun 30, 2022 | -31.90% |
| Mar 31, 2022 | -27.90% |
| Dec 31, 2021 | -11.84% |
| Sep 30, 2021 | 3.58% |
| Jun 30, 2021 | -18.47% |
| Mar 31, 2021 | -14.87% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 13.79% |
| Jun 30, 2020 | 12.94% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | -14.87% |
| Sep 30, 2019 | 35.43% |
| Jun 30, 2019 | -34.08% |
| Mar 31, 2019 | -37.97% |
| Dec 31, 2018 | -76.23% |
| Sep 30, 2018 | -5.39% |
| Jun 30, 2018 | -43.10% |
| Dec 31, 2017 | -61.54% |